Search - tctmd.com

Displaying 861 - 880 of 1424

Sort: Relevancy | Date

Presentation TVT 2016

TAVR in Mitral Valve Case Presentation (VIV): Focus on Imaging

Presenter: Douglas C Shook

June 16, 2016

Presentation TVT 2016

TVT 1126: On-Pump Beating-Heart Direct Transatrial Implantation of Edwards Sapien 3 Valve for Mitral Stenosis With Severely Calcified Annulus

Presenter: Mohammad Sarraf, MD

June 16, 2016

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

Presentation TVT 2016

TVT 1035: Transapical Implantation of Mechanically Expanding Lotus Valve in a Native Severe Calcific Mitral Valve Stenosis

Presenter: Renzo Pessotto

June 16, 2016

Presentation TVT 2016

TAVR in Mitral Valve Bioprothesis (VIV): Anatomical Considerations

Presenter: Danny Dvir

June 16, 2016

Presentation TVT 2016

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

Presenter: Yoshifumi Nakajima, MD

June 16, 2016

Presentation TVT 2016

The Minimalist TAVR Credo: Keep It Simple! Impact on Clinical Pathway Efficiencies and Outcomes

Presenter: Vasilis Babaliaros

June 16, 2016

Presentation TVT 2016

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

Presenter: Vikas Aggarwal, MD

June 16, 2016

Presentation TVT 2016

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

Presenter: Creighton W. Don

June 16, 2016

Presentation TVT 2016

TAVR Bioskills

Presenter: Mark Reisman

June 16, 2016

Presentation TVT 2016

Appropriate Use of TAVR Now and in the Future: A Surgeons Perspective

Presenter: Neil E. Moat

June 16, 2016

Presentation TVT 2016

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Presenter: Martin B. Leon

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Presentation TVT 2015

Should All Repositionable Valves Have Intraprocedural TEE?

Presenter: Ian T. Meredith

June 06, 2015

Presentation TVT 2015

Impact of Second-Generation TAVR on Preprocedural Imaging

Presenter: Hasan Jilaihawi

June 06, 2015

Presentation TVT 2015

Procedural Guidance by TEE: Do We Really Need Fluoroscopy and Contrast?

Presenter: Rebecca T. Hahn

June 06, 2015

Presentation TVT 2015

Assessment for the Need for Postdeployment Dilatation or an Additional Transcatheter Valve: TEE Guidance, Hemodynamics, or Both

Presenter: Jean Buitheiu

June 06, 2015

Presentation TVT 2015

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

Presenter: Jeffrey J. Popma

June 06, 2015

Presentation TVT 2015

When Do We Take the LVOT Into Account in Device Sizing and Why

Presenter: Hasan Jilaihawi

June 06, 2015

Presentation TVT 2015

The Best Point in RR to Measure and Why

Presenter: Jonathon A. Leipsic

June 06, 2015

Advertisement

TAVR in Mitral Valve Case Presentation (VIV): Focus on Imaging

TVT 1126: On-Pump Beating-Heart Direct Transatrial Implantation of Edwards Sapien 3 Valve for Mitral Stenosis With Severely Calcified Annulus

The Case for and Against Cerebral Embolic Protection During TAVR

TVT 1035: Transapical Implantation of Mechanically Expanding Lotus Valve in a Native Severe Calcific Mitral Valve Stenosis

TAVR in Mitral Valve Bioprothesis (VIV): Anatomical Considerations

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

The Minimalist TAVR Credo: Keep It Simple! Impact on Clinical Pathway Efficiencies and Outcomes

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

TAVR Bioskills

Appropriate Use of TAVR Now and in the Future: A Surgeons Perspective

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Should All Repositionable Valves Have Intraprocedural TEE?

Impact of Second-Generation TAVR on Preprocedural Imaging

Procedural Guidance by TEE: Do We Really Need Fluoroscopy and Contrast?

Assessment for the Need for Postdeployment Dilatation or an Additional Transcatheter Valve: TEE Guidance, Hemodynamics, or Both

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

When Do We Take the LVOT Into Account in Device Sizing and Why

The Best Point in RR to Measure and Why

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content